Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-25-043848
Filing Date
2025-03-24
Accepted
2025-03-24 16:15:40
Documents
16
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A inva-20241231.htm   iXBRL 10-K/A 314494
2 EX-23.3 inva-ex23_3.htm EX-23.3 3145
3 EX-31.1 inva-ex31_1.htm EX-31.1 15096
4 EX-31.2 inva-ex31_2.htm EX-31.2 14294
5 EX-32 inva-ex32.htm EX-32 16295
6 EX-99.1 inva-ex99_1.htm EX-99.1 1023615
  Complete submission text file 0000950170-25-043848.txt   1670290

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT inva-20241231.xsd EX-101.SCH 43755
18 EXTRACTED XBRL INSTANCE DOCUMENT inva-20241231_htm.xml XML 11016
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30319 | Film No.: 25764350
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)